Why it was recalled
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
Product description
Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.
Lot numbers, UPCs & expiration codes
Lot # 34016752A, Exp. 09/16. Lot # 34016753A, Exp. 09/16.
Where it was sold
Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1095-2014
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jan 24, 2014
- FDA report date
- Mar 12, 2014
- Quantity
- 35746 capsules
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Teva Pharmaceuticals USA
Original FDA data
Every field from FDA enforcement report D-1095-2014, exactly as published.
Show all FDA fields
- City
- Horsham
- State
- PA
- Status
- Terminated
- Country
- United States
- Event ID
- 67412
- Address
- 425 Privet Rd
- Code information
- Lot # 34016752A, Exp. 09/16. Lot # 34016753A, Exp. 09/16.
- Postal code
- 19044-1220
- Report date
- Mar 12, 2014
- Product type
- Drugs
- Recall number
- D-1095-2014
- Classification
- Class II
- Recalling firm
- Teva Pharmaceuticals USA
- Product quantity
- 35746 capsules
- Termination date
- Oct 8, 2014
- Reason for recall
- CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.
- Distribution pattern
- Nationwide.
- Recall initiation date
- Jan 24, 2014
- Initial firm notification
- Letter
- Center classification date
- Feb 28, 2014